Results 141 to 150 of about 26,112 (181)

Inhibitory role of angiopoietin‑like 4 for cancer progression in oropharyngeal squamous cell carcinoma. [PDF]

open access: yesOncol Rep
Mikoshiba T   +7 more
europepmc   +1 more source

Effect of empagliflozin on urinary albumin excretion and hypoxic biomarkers in early diabetic kidney disease: A randomised double-blind, placebo-controlled trial. [PDF]

open access: yesDiabetes Obes Metab
Makino H   +14 more
europepmc   +1 more source

Novel biomarkers distinguish heart failure with preserved vs reduced ejection fraction. [PDF]

open access: yesESC Heart Fail
Hage C   +6 more
europepmc   +1 more source

Angiopoietin-like protein 8 accelerates atherosclerosis in ApoE−/− mice [PDF]

open access: yesAtherosclerosis, 2020
Angiopoietin-like protein 8 (ANGPTL8) is a hormone involved in regulating lipid metabolism. Patients with coronary artery disease have markedly higher plasma levels of ANGPTL8 than controls; however, the role of ANGPTL8 in atherosclerosis has not been explored.
Yunxiao Yang, Huahui Yu, Juan Li
exaly   +3 more sources

Regulation of angiopoietin-like protein 8 expression under different nutritional and metabolic status

open access: yesEndocrine Journal, 2019
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease with increasing prevalence worldwide. Angiopoietin-like protein 8 (ANGPTL8), a member of the angiopoietin-like protein family, is involved in glucose metabolism, lipid metabolism, and energy homeostasis and believed to be associated with T2DM.
Chang Guo, Zhicong Zhao, Xia Deng
exaly   +4 more sources

Home - About - Disclaimer - Privacy